Related Experiment Videos

[Treatment for hormone-refractory or relapsing prostatic cancer]

Y Hirao1, S Ozono, E Okajima

  • 1Department of Urology, Nara Medical University, Japan.

Gan to Kagaku Ryoho. Cancer & Chemotherapy
|March 1, 1996
PubMed
Summary

Chemotherapy offers a 49.6% response rate for advanced prostate cancer, with higher efficacy in primary treatment (67.2%) versus hormone-refractory cases (23.9%). Further research is needed for better agents and standardized criteria in prostate cancer chemotherapy.

Related Concept Videos